. 2020 Oct 26;36(1):15–33. doi: 10.1080/14756366.2020.1837124
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Multi-CDK inhibitors 1–5 bearing similar pharmacophoric features.